41 – 50 of 76
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis
2016) In Annals of the Rheumatic Diseases(
- Contribution to journal › Article
-
Mark
Off-label use of rituximab for systemic lupus erythematosus in Europe
(
- Contribution to journal › Scientific review
-
Mark
A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach
(
- Contribution to journal › Article
- 2015
-
Mark
Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial.
(
- Contribution to journal › Article
-
Mark
Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial
(
- Contribution to journal › Article
-
Mark
Does disease activity at start of biologic therapy influence work-loss in RA patients?
2015) In Rheumatology (Oxford, England)(
- Contribution to journal › Article
-
Mark
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
(
- Contribution to journal › Article
-
Mark
Brief report: enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi-biomarker disease activity score as an inclusion criterion.
(
- Contribution to journal › Article
-
Mark
Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort
(
- Contribution to journal › Article
-
Mark
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
(
- Contribution to journal › Article